Cosciens Biopharma Stock Price on September 24, 2024
| CSCI Stock | 3.13 0.04 1.29% |
Below is the normalized historical share price chart for COSCIENS Biopharma extending back to May 10, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of COSCIENS Biopharma stands at 3.13, as last reported on the 1st of December, with the highest price reaching 3.20 and the lowest price hitting 3.04 during the day.
If you're considering investing in COSCIENS Stock, it is important to understand the factors that can impact its price. COSCIENS Biopharma secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of volatility over the last 3 months. COSCIENS Biopharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm COSCIENS Biopharma's mean deviation of 2.09, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide.
As of now, COSCIENS Biopharma's Total Stockholder Equity is increasing as compared to previous years. The COSCIENS Biopharma's current Common Stock Shares Outstanding is estimated to increase to about 85.8 M, while Stock Based Compensation is projected to decrease to under 120.9 K. . COSCIENS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of May 2000 | 200 Day MA 7.1088 | 50 Day MA 5.3758 | Beta 2.274 |
COSCIENS |
Sharpe Ratio = -0.1105
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CSCI |
Estimated Market Risk
| 2.96 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average COSCIENS Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of COSCIENS Biopharma by adding COSCIENS Biopharma to a well-diversified portfolio.
Price Book 0.4942 | Enterprise Value Ebitda 3.3303 | Price Sales 2.6615 | Shares Float 2.8 M | Earnings Share (2.69) |
Related Headline
Eliem Therapeutics Headline on 24th of September 2024
500,000 Shares in Eliem Therapeutics, Inc. Acquired by Ally ... by news.google.com
500,000 Shares in Eliem Therapeutics, Inc. Acquired by Ally Bridge Group NY LLC MarketBeat
COSCIENS Biopharma Valuation on September 24, 2024
It is possible to determine the worth of COSCIENS Biopharma on a given historical date. On September 24, 2024 COSCIENS was worth 3.85 at the beginning of the trading date compared to the closed value of 3.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of COSCIENS Biopharma stock. Still, in general, we apply an absolute valuation method to find COSCIENS Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of COSCIENS Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against COSCIENS Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 3.83 | 4.02 | 3.64 | 3.90 | 3,676 | |
09/24/2024 | 3.85 | 4.02 | 3.65 | 3.80 | 6,241 |
| 3.71 | 3.95 | 3.71 | 3.84 | 5,076 |
| Backtest COSCIENS Biopharma | | | COSCIENS Biopharma History | | | COSCIENS Biopharma Valuation | Previous | Next |
COSCIENS Biopharma Trading Date Momentum on September 24, 2024
| On September 25 2024 COSCIENS Biopharma was traded for 3.84 at the closing time. The top price for the day was 3.95 and the lowest listed price was 3.71 . The trading volume for the day was 5.1 K. The trading history from September 25, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 1.05% . The overall trading delta against the current closing price is 2.63% . |
COSCIENS Biopharma Fundamentals Correlations and Trends
By evaluating COSCIENS Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among COSCIENS Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. COSCIENS financial account trend analysis is a perfect complement when working with valuation or volatility modules.About COSCIENS Biopharma Stock history
COSCIENS Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for COSCIENS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in COSCIENS Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing COSCIENS Biopharma stock prices may prove useful in developing a viable investing in COSCIENS Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 78.3 M | 85.8 M |
COSCIENS Biopharma Quarterly Net Working Capital |
|
COSCIENS Biopharma Stock Technical Analysis
COSCIENS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
COSCIENS Biopharma Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
COSCIENS Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
COSCIENS Biopharma December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how COSCIENS Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading COSCIENS Biopharma shares will generate the highest return on investment. By undertsting and applying COSCIENS Biopharma stock market strength indicators, traders can identify COSCIENS Biopharma entry and exit signals to maximize returns
COSCIENS Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for COSCIENS Biopharma's price direction in advance. Along with the technical and fundamental analysis of COSCIENS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of COSCIENS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | 1.9 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for COSCIENS Stock analysis
When running COSCIENS Biopharma's price analysis, check to measure COSCIENS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSCIENS Biopharma is operating at the current time. Most of COSCIENS Biopharma's value examination focuses on studying past and present price action to predict the probability of COSCIENS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSCIENS Biopharma's price. Additionally, you may evaluate how the addition of COSCIENS Biopharma to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |